Swedish medtech start-up Capitainer says its qDBS card has scored highly in a major new study published in Clinica Chimica Acta on the advantages of volumetric microsampling DBS devices in monitoring of patients with phenylketonuria (PKU). The study was necessary according to the authors, because although measurement of dried blood spot phenylalanine (Phe) is central […]
EpiEndo Pharmaceuticals, a clinical-stage biopharmaceutical company developing disease-modifying therapeutics for chronic respiratory disorders, has received regulatory and ethics approval to commence a Lipopolysaccharide (LPS) challenge clinical trial with lead molecule EP395. EP395 is an orally available macrolide or ‘Barriolide’ with reduced antimicrobial activity which aims to address the unmet medical need for a treatment for […]
Lifespin, based in Regensburg, Germany, with offices in Boston, Massachusetts, has launched a new commercial service that, for the first time, will provide the pharmaceutical and biobanking industry with access to its proprietary metabolic database, as well as its advanced interpretive software to assist in various phases of drug research, development, and manufacturing.
Absolute Antibody, an industry-leading provider of recombinant antibody products and services, is expanding its manufacturing facility in northeast England. The increased laboratory space includes a major investment in new automation for Next Generation Sequencing (NGS), expression and purification (HPLC) to enhance recombinant antibody production workflows. The additional space and equipment will enable Absolute Antibody to […]
BD (Becton, Dickinson and Company) and Accelerate Diagnostics, an innovator of rapid in-vitro diagnostics in microbiology, announced a worldwide commercial collaboration agreement where BD will offer Accelerate’s rapid testing solution for antibiotic resistance and susceptibility. The test offers results in hours, versus one to two days with some traditional laboratory methods.
ProBioGen and City of Hope, one of the largest cancer research and treatment organizations in the United States, have signed an non-exclusive commercial license agreement that will allow City of Hope to manufacture its innovative synthetic MVA-based CMV vaccine using ProBioGen’s cell-based and scalable viral manufacturing platform AGE1.CR.pIX.
Biopharmaceutical company Mogrify and Astellas Pharma have initiated a collaborative research agreement on in vivo regenerative medicine approaches to address sensorineural hearing loss.
Indica Labs, an industry leader in quantitative digital pathology and image management solutions, and The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics (iCAIRD), will collaborate on the development of an AI-based digital pathology solution for the detection of cancer within lymph nodes from colorectal surgery cases. The primary aim of the research project […]
Vyon® porous plastics from Porvair Sciences are the perfect material for filtration applications in the healthcare and medical devicemarket
PhoreMost to deploy its SITESEEKER platform to identify novel targets for Roche’s discovery programmes
November 2025
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.